Here are five things to know:
1. The licensing agreement allows Xtant Medical to use the company’s proprietary OsteoSync Ti technology.
2. A porous titanium scaffold, OsteoSync Ti technology features a high friction coefficient which ensures high initial implant stability.
3. The technology’s open pore geometry and micro-texturing promote bone ingrowth.
4. At five weeks, preclinical testing revealed OsteoSync Ti technology enabled bone attachment strength nearly twice that of titanium plasma spray as well as seven times that of PEEK material.
5. Xtant Medical will showcase its first devices featuring the OsteoSync Ti technology at the North American Spine Society annual meeting, in Orlando, Fla. from Oct. 25 to Oct. 28.
More articles on devices:
80% of patients with Intralink-Spine Réjuve System see exceptional outcomes at 6 months — 6 takeaways
Invibio & Double Medical host workshop on PEEK-OPTIMA spinal cages — 6 points
Stem cells, PRP technology boost global orthobiologics market: 5 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
